Literature DB >> 10784130

Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke.

T Kano1, Y Katayama, E Tejima, E H Lo.   

Abstract

In this study, the effects of early vs. delayed tPA treatment on the development of hemorrhagic transformation was compared in a rat thromboembolic model of stroke. Fibrinolysis was performed by administering tPA intravenously at 2 or 6 h after ischemic onset. Twenty-four hours later, confluent hemorrhagic infarction was observed only in rats treated with tPA at 6 h at the rate of 50%. In this delayed treatment group, significantly increased numbers of polymorphonuclear leukocytes (PMNL) were observed to accumulate inside microvessels within the ischemic core. PMNL accumulation may be related to the induction of hemorrhagic infarction after delayed tPA treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10784130     DOI: 10.1016/s0006-8993(99)02276-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.

Authors:  Rong Jin; Adam Y Xiao; Jarvis Li; Min Wang; Guohong Li
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

2.  Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.

Authors:  Rong Jin; Adam Y Xiao; Shan Liu; Min Wang; Guohong Li
Journal:  Stroke       Date:  2018-05-29       Impact factor: 7.914

3.  Combination Therapy Using tPA and Edaravone Improves the Neurotoxic Effect of tPA.

Authors:  T Kano; T Harada; T Hirayama; Y Katayama
Journal:  Interv Neuroradiol       Date:  2007-06-27       Impact factor: 1.610

Review 4.  Preclinical stroke research--advantages and disadvantages of the most common rodent models of focal ischaemia.

Authors:  I M Macrae
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia.

Authors:  Sophie Gautier; Thavarak Ouk; Olivier Petrault; Jacques Caron; Régis Bordet
Journal:  Br J Pharmacol       Date:  2009-02-04       Impact factor: 8.739

6.  Translational stroke research using a rabbit embolic stroke model: a correlative analysis hypothesis for novel therapy development.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2010-04-02       Impact factor: 6.829

7.  MR imaging enhancement patterns as predictors of hemorrhagic transformation in acute ischemic stroke.

Authors:  Katie D Vo; Fernando Santiago; Weili Lin; Chung Y Hsu; Yueh Lee; Jin-Moo Lee
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

8.  Efficacy of recombinant annexin 2 for fibrinolytic therapy in a rat embolic stroke model: a magnetic resonance imaging study.

Authors:  Yoji Tanaka; Hideto Ishii; Megumi Hiraoka; Naoyuki Miyasaka; Toshihiko Kuroiwa; Katherine A Hajjar; Tsukasa Nagaoka; Timothy Q Duong; Kikuo Ohno; Masayuki Yoshida
Journal:  Brain Res       Date:  2007-07-06       Impact factor: 3.252

9.  Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles?

Authors:  Renée J Turner; Glen C Jickling; Frank R Sharp
Journal:  Transl Stroke Res       Date:  2011-02-12       Impact factor: 6.829

10.  Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage.

Authors:  Victor Friedrich; Rowena Flores; Artur Muller; Weina Bi; Ellinor Ib Peerschke; Fatima A Sehba
Journal:  J Neuroinflammation       Date:  2011-08-19       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.